Pulmonary Services

UAB Pulmonary Services provides comprehensive treatment of medical conditions involving the lungs. It is part of our nationally recognized Division of Pulmonary, Allergy, and Critical Care Medicine, which focuses on respiratory, pulmonary vascular, and allergic disorders. Our highly trained physicians work with general practitioners and specialists from other fields to collaborate on the diagnosis and treatment of such lung diseases as cystic fibrosis, acute respiratory distress syndrome (ARDS), and lung cancer. We also treat patients with sleep disorders. UAB Pulmonary Services offers the latest and most technologically advanced procedures, including lung transplants and ECMO (extracorporeal membrane oxygenation).


UAB Pulmonary Services is ranked among the best programs of its kind in the nation, and our physicians are consistently listed among the Best Doctors in America for respiratory disease. We serve patients at our main campus and also at our convenient neighborhood clinics in Hoover and Gardendale.

Most UAB Pulmonary Services doctors are triple board-certified in internal medicine, critical care, and pulmonary medicine. They serve on national boards and specialty organizations, speak at national conferences, publish in scientific and medical journals, and help conduct research that is recognized nationally and internationally. Our physicians are continually seeking new ways to treat lung disease and improve the techniques and care for transplant patients while contributing to the body of knowledge about lung disease. We have the only nationally accredited Sleep Medicine Fellowship Training Program in Alabama.

Many UAB Pulmonary Services physicians carry out research funded by the National Institutes of Health (NIH) to gain a better understanding of lung disease and its treatments or help turn new discoveries into therapies. Our physicians have served as presidents of many national societies, including the American College of Chest Physicians, the Association of Subspecialty Professors, and the Association of Pulmonary and Critical Care Medicine Program Directors. The excellence of our clinical and research programs has been recognized with our membership in the NIH-funded COPD and IPF Clinical Research networks (COPDnet and IPFnet, respectively), as well as the American Lung Association's Asthma Clinical Research Network and the Cystic Fibrosis Foundation’s Therapeutics Development Network. The World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) and the Foundation for Sarcoidosis Research (FSR) have recognized UAB as a Sarcoidosis Center of Excellence.

Conditions treated by UAB Pulmonary physicians include:

  • Hamman-Rich Syndrome
  • Hard-Metal Pneumoconiosis
  • Honeycomb Lung
  • Hypersensitivity Pneumonitis (HSP)
  • Idiopathic Pulmonary Fibrosis
  • Interstitial Lung Disease
  • Lymphangioleiomyomatosis (LAM)
  • Lymphocytic Interstitial Pneumonia (LIP)
  • Lung Cancer
  • Lung Disease
  • Mixed Connective Tissue Disease
  • Nonspecific Interstitial Pneumonia (NSIP)
  • Pigeon Breeder’s Disease
  • Pneumonia
  • Pneumoconiosis
  • Polymyositis, Dermatomyositis
  • Pulmonary Alveolar Microlithiasis
  • Pulmonary Eosinophilic Granuloma (EG), Histiocytosis X (HX), or Langerhans Cell Granulomatosis
  • Pulmonary Fibrosis
  • Pulmonary Hypertension
  • Pulmonary Phospholipoproteinosis
  • Respiratory Bronchiolitis
  • Respiratory Bronchiolitis-associated Interstitial Lung Disease (RB-ILD)
  • Rheumatoid Lung
  • Sarcoidosis
  • Scleroderma Lung
  • Shortness of Breath
  • Silicosis
  • Sleep-Disordered Breathing
  • Smoker’s Bronchiolitis
  • Systemic Lupus Erythematosus (Lupus Lung)
  • Usual interstitial pneumonia (UIP)





Low-Dose CT Screening for Lung Cancer

Low-dose CT (computed tomography) screening for lung cancer is a way of finding tumors before they become too advanced and become difficult to treat successfully. This screening method has been shown to reduce the risk of death from lung cancer in high-risk patients by 20% compared to chest X-ray alone. However, many lung nodules (growths) detected from the low-dose CT screening are not cancerous, so follow-up CT scans or other tests may be needed to determine the presence of cancer.

The U.S. Preventive Services Task Force (USPSTF) recommends annual screening for lung cancer with low-dose CT scans in adults age 55-80 who have a 30-pack-per-year smoking history and currently smoke or quit within the last 15 years. Medicare approved screening for patients age 55-77, and this is the age group that UAB Medicine provides screening for. Screening is stopped once a person has not smoked for 15 years, develops a health problem that seriously limits life expectancy, or does not wish to have lung surgery. The CT scan itself lasts only about 20 seconds. Patients being screened are asked to hold their breath for a few seconds as the scan is performed. All patients must be referred for the test by a physician after a shared decision-making appointment. It is important that a responsible health care provider manages follow-up care for patients with a positive test.

Click here to learn More about Screening >>
Click here for a Screening Referral Form >>


UAB is an active participant in research and clinical trials. We encourage you to speak to your physician about research and clinical trial options and browse the link below for more information.

View Clinical Trials